MMEA
EW icon

Mark Morris et al’s Edwards Lifesciences EW Stock Holding History

Mark Morris et al’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$34K Buy
+3,000
New +$35.5K 0.01% 111

Other funds holding EW

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Mark Morris et al's EW Position: Q2 2013 in Review

Mark Morris et al opened a new position in Edwards Lifesciences (EW) in Q2 2013: 3,000 shares worth $34K. The stake represents 0.01% of the portfolio and ranks #111 among its holdings.

375 funds tracked by Wall St. Rank hold EW as of Q2 2013.

  • Mark Morris et al held 3,000 shares of Edwards Lifesciences worth $34K as of Q2 2013.
  • Edwards Lifesciences was a new Mark Morris et al position in Q2 2013.
  • Edwards Lifesciences made up 0.01% of Mark Morris et al's portfolio in Q2 2013, its #111 holding.
  • 375 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2013.

Based on Mark Morris et al's 13F filing for Q2 2013, filed 13 Aug 2013.